MAYRA MUNOZ: Open Payments
NPI 1730869827 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 28 payments from 18 companies in 2025. Trend: 2023 $206 · 2024 $1,084 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 5 | $139 |
| AstraZeneca Pharmaceuticals LP | 1 | $102 |
| Lilly USA, LLC | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Astellas Pharma US Inc | 2 | $51 |
| Dexcom, Inc. | 1 | $50 |
| PFIZER INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Eisai Inc. | 1 | $33 |
| Neuronetics, Inc. | 1 | $32 |
Products named: Cologuard Collection Kit, AIRSUPRA, Kerendia, Veozah, Dexcom G6 Transmitter, MOUNJARO, PREVNAR 20, Leqembi.
Industry payments across MD — which companies pay providers there.
